Owner and principal consultant
HMC-regulation
Aseret, HaDarom, Israel
Hagit is a seasoned regulatory affairs and drug development executive with a robust scientific background and over 20 years of experience in the biotech, pharmaceutical, and combination product industries. Her expertise spans the entire spectrum of drug development, from early-stage research to post-marketing approval.
Hagit has extensive experience in nonclinical and clinical studies, GMP requirements, and managing meetings with Health Authorities (HAs). She is adept at preparing and submitting regulatory documents to the FDA, EMA, and other global Health Authorities. Her skills include developing regulatory and drug development strategies, conducting gap analyses, and compiling complete registration files.
Currently, Hagit leverages her vast experience as an independent consultant, providing regulatory consultation services to companies, bio-med incubators, and venture capital firms. She offers her expertise either on a permanent basis, leading regulatory affairs activities, or on specific projects.
Disclosure information not submitted.
Thursday, May 15, 2025
14:30 - 15:30 CEST
EMA and FDA Programs to Accelerate Innovation in Treating Unmet Medical Needs
Thursday, May 15, 2025
16:45 - 17:45 CEST